The role of IL-12 and IL-4 in Leishmania major infection

Chemical Immunology

Volumn 68, Issue , 1997, Pages 86-109

  Mattner, Frank ^a   Alber, Gottfried ^a   Magram, Jeanne ^b   Kopf, Manfred ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b HOFFMANN LA ROCHE INC   (United States)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL CELL; DISEASE PREDISPOSITION; HELPER CELL; IMMUNOMODULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE CONTROL; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS;

EID: 0030883357     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058696     Document Type: Review

References (68)

1. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1997;383: 787-793.
2. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635-673.
3. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TA, Bond MW, Moore KW, Sher A, Fiorentino DF: Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 1991;123:209-229.
4. Kaplan MH, Sun YL, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996;382:174-177.
5. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihle JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-174.
6. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
7. Kaplan MH, Schindler U, Smiley ST, Grusby MJ: Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996;4:313-319.
8. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:630-633.
9. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signalling. Nature 1996;380:627-630.
10. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages (see comments). Science 1993;260:547-549.
11. Tripp CS, Wolf SF, Unanue ER: Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90: 3725-3729.
12. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A: Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994;153:2533-2543.
13. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995;84:423-432.
14. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-177.
15. Titus RG, Ceredig R, Cerottini JC, Louis JA: Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmamasis in genetically-susceptible BALB/c mice. J Immunol 1985;135: 2108-2114
16. Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM: Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ cells. J Immunol 1987;139:1303-1309.
17. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM: Reciprocal expression of interferon gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
18. Locksley RM, Reiner SL, Hatam F, Littman DR, Killeen N: Helper T cells without CD4: Control of leishmaniasis in CD4-deficient mice. Science 1993;261:1448-1451.
19. Wang ZE, Reiner SL, Hatam F, Heinzel FP, Bouvier J, Turck CW, Locksley RM: Targeted activation of CD8 cells and infection of beta-2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J Immunol 1993;151:2077-2086.
20. Heinzel FP, Sadick MD, Mutha SS, Locksley RM: Production of interferon gamma, interleukin-2, interleukin-4, and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991;88:7011-7015.
21. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM: Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990;171:115-127.
22. Sadick MD, Street N, Mosmann TR, Locksley RM: Cytokine regulation of murine leishmaniasis: Interleukin-4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice. Infect Immun 1991;59:4710-4714.
23. Chatelain R, Varkila K, Coffman RL: IL-4 induces a Th2 response in Leishmania mayor-infected mice. J Immunol 1992;148:1182-1187.
24. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA: Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 1989;143:266-274.
25. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM: CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994;179: 1367-1371.
26. Swihart K, Fruth U, Messmer N, Hug K, Behin R, Huang S, Del-Giudice G, Aguet M, Louis JA: Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med 1995;181:961-971.
27. Sypek JP, Chung CL, Mayor SE, Subramanyara JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
28. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-1509.
29. Scharton Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P: IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995;154:5320-5330.
30. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996;26:1553-1559.
31. Kopf M, Brombacher F, Kohler G, Kienzle G, Widmann KH, Lefrang K, Humborg C, Ledermann B, Solbach W: IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med 1996; 184:1127-1136.
32. Carrera L, Gazinelli RT, Badolato R, Hieny S, Muller W, Kühn R, Sacks DL: Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996;183:515-526.
33. Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM: Leishmania promastigotes evade interleukin-12 induction by macrophages and stimulate a broad range of cytokines from CD4+ cells during initiation of infection. J Exp Med 1994;179:447-456.
34. Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA: In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur J Immunol 1995;25:3298-3307.
35. Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997;185:817-824.
36. Guler ML, Gorham JD, Hsieh C-S, Mackey AJ, Steen RG, Dietrich WF, Murphy KM: Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996;271:984-987.
37. Skeiky YA, Guderian JA, Benson DR, Bacelar O, Carvalho EM, Kubin M, Badaro R, Trinchieri G, Reed SG: A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin-12. J Exp Med 1995; 181:1527-1537.
38. Gazzinelli RT, Wysocka M, Hieny S, Scharton Kersten T, Cheever A, Kuhn R, Muller W, Trinchieri G, Sher A: In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996;157:798-805.
39. Dai WJ, Kohler G, Brombacher F: Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 1997;158:2259-2267.
40. Bretscher P, Cohn-M: A theory of self-nonself discrimination. Science 1970;169:1042.
41. Lafferty KJ, Prowse SJ, Simeonovic CJ: Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu Rev Immunol 1983;1:143-173.
42. Jenkins MK: The ups and downs of T cell costimulation. Immunity 1994;1:443-446.
43. Bluestone J: New perspectives of CD28-B7 mediated T cell costimulation. Immunity 1995;2:555-559.
44. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van-Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
45. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167-178.
46. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, Geha RS: CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 1994;91:12135-12139.
47. Renshaw BR, Fanslow WR, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL, Maliszewski CR: Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994;180: 1889-1900.
48. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1994;1:423-431.
49. Grewal IS, Flavell RA: A central role of CD40 ligand in the regulation of CD4+ T cell responses. Immunol Today 1996;17:410-414.
50. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR: CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996;4: 283-289.
51. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H: Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275-281.
52. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley B Jr, Ruddle NH, McMahon-Pratt D, Flavell RA: Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 1996;4:263-273.
53. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.
54. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
55. Waterhousc P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995;270:985-988.
56. Brown DR, Green JM, Moskowitz NH, Davis M, Thompson CB, Reiner SL: Limited role of CD28-mediated signals in T helper subset differentiation. J Exp Med 1996;184:803-810.
57. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352:621-624.
58. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 1993;262:1059-1061.
59. Morris L, Troutt AB, Handman E, Kelso A: Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J Immunol 1992;149:2715-2721.
60. Menon JN, Bretscher PA: Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur J Immunol 1996;26:243-249.
61. Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA: The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993;75: 985-995.
62. Seder RA, Paul WE, Davis MM, Fazekas de St Groth B: The presence of interleukin-4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992;176:1091-1098.
63. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992;89:6065-6069.
64. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P: Lack of interteron-γ receptor β chain and the prevention of interferon-γ signaling in Th1 cells. Science 1995;269: 245-247.
65. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H: Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992;257:539-542.
66. Noben-Trauth N, Kropf P, Muller I: Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-990.
67. Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, Aebischer T: Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun 1993;61:3459-3465.
68. Shankar AH, Titus RG: T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 1995;181:845-855.